Updates from The Motley Fool

Latest updates on Kite Pharma from  The Fool has written over 100 articles on Kite Pharma.
CAR-T Stocks: Time to Panic?

Juno Therapeutics was forced to halt a clinical trial for its lead CAR-T therapy, causing the sto...

3 Biotech Stocks to Buy in July

Looking for hot biotech stocks to buy in July? Here are three Motley Fool healthcare contributors...

Stock Performance

View Interactive KITE Charts
Sponsored by

Key Data Points

Primary metrics and data points about Kite Pharma.
Current Price: $54.66
Prev Close: $54.47
Open: $54.49
Bid: $53.50
Ask: $55.00
Day's Range: $53.60 - $55.20
52wk Range: $39.82 - $64.30
Volume: 611,163
Avg Vol 787,330
Market Cap: $2B
P/E (ttm): -11.89
EPS (ttm): ($4.58)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Kite Pharma.
CAPS Rating 4 out of 5
118 Outperform
11 Underperform
CAPS All Stars
35 Outperform
3 Underperform

How do you think Kite Pharma will perform against the market?

You pick for Kite Pharma is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

Business Summary

Industry, sector and description for Kite Pharma.


  • Exchange: NASDAQ